STRANG JOHN,OKSCHE ALEXANDER,HARRIS STEPHEN,SMITH KEVIN,MOTTIER LUCIE HELENE JEANNE
申请号：
NZ70593312
公开号：
NZ705933A
申请日:
2012.05.11
申请国别(地区):
NZ
年份:
2016
代理人:
摘要：
Disclosed is an intranasal pharmaceutical dosage form comprising a dosing unit comprising naloxone or a pharmaceutically acceptable salt thereof dissolved in an application fluid in a concentration of between equivalent to 20 mg naloxone HCl per ml application fluid and 50 mg naloxone HCl per ml application fluid, wherein said dosing unit contains a volume of 100 µl to 200 µl application fluid. The dosage forms are useful in the treatment of opioid overdose.
